Envestnet Asset Management Inc Amneal Pharmaceuticals, Inc. Transaction History

Envestnet Asset Management Inc

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$5.24 - $6.34 $833 - $1,008	-159 Reduced 0.39%	41,050 $248,000
Q4 2023 Feb 13, 2024	BUY	$3.36 - $6.21 $42,749 - $79,009	12,723 Added 44.66%	41,209 $250,000
Q3 2023 Nov 13, 2023	BUY	$2.76 - $4.59 $78,621 - $130,750	28,486 New	28,486 $120,000
Q2 2022 Aug 03, 2022	SELL	$3.01 - $4.46 $22,433 - $33,240	-7,453 Reduced 26.86%	20,295 $65,000
Q1 2022 May 04, 2022	BUY	$3.9 - $4.89 $1,084 - $1,359	278 Added 1.01%	27,748 $116,000
Q4 2021 Feb 04, 2022	BUY	$3.95 - $5.85 $66,320 - $98,221	16,790 Added 157.21%	27,470 $132,000
Q3 2021 Oct 07, 2021	SELL	$4.31 - $5.64 $3,215 - $4,207	-746 Reduced 6.53%	10,680 $57,000
Q2 2021 Aug 04, 2021	BUY	$5.12 - $6.82 $5,335 - $7,106	1,042 Added 10.03%	11,426 $59,000
Q1 2021 May 04, 2021	SELL	$4.74 - $7.38 $71 - $110	-15 Reduced 0.14%	10,384 $70,000
Q4 2020 Feb 02, 2021	SELL	$3.95 - $5.42 $3,444 - $4,726	-872 Reduced 7.74%	10,399 $48,000
Q3 2020 Oct 09, 2020	BUY	$3.54 - $5.27 $39,899 - $59,398	11,271 New	11,271 $44,000
Q2 2019 Aug 02, 2019	SELL	$6.44 - $14.29 $355,925 - $789,779	-55,268 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$11.87 - $14.84 $103,019 - $128,796	8,679 Added 18.63%	55,268 $783,000
Q4 2018 Feb 13, 2019	BUY	$13.09 - $21.49 $609,850 - $1 Million	46,589 New	46,589 $630,000
Q3 2018 Nov 14, 2018	SELL	$16.4 - $24.27 $150,502 - $222,725	-9,177 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$13.95 - $20.2 $128,019 - $185,375	9,177 New	9,177 $151,000

190

140M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.34B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.